Back to Journals » Cancer Management and Research » Volume 15

iNOS is Associated with Tumorigenicity as an Independent Prognosticator in Human Intrahepatic Cholangiocarcinoma [Retraction]

Authors Liu S , Jiang J, Huang L, Jiang Y, Yu N, Liu X, Lv Y, Li H, Zou L, Peng C, Yu X, Jiang B 

Received 2 August 2023

Accepted for publication 2 August 2023

Published 10 August 2023 Volume 2023:15 Pages 809—810

DOI https://doi.org/10.2147/CMAR.S433550



Liu S, Jiang J, Huang L, et al. Cancer Manag Res. 2019;11:8005–8022.

We, the Editors and Publisher of Cancer Management and Research, have retracted the published article. Concerns were raised following the authors request to correct Figure 4. It was found images in Figure 4 had been duplicated. Specifically,

  • The images for Figure 4C, 0h, 0 µmol/l and 25 µmol/l, have been duplicated.

When approached for an explanation, the authors were cooperative and provided some original data for their study, however, the provided data was not satisfactory, and the results could not be adequately verified. As verifying the validity of the published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors do not agree with this decision.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.